Showing results (181-190 of 187) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 187 results.
International Journal of Molecular Sciences|June 20, 2018
Graviola (Annona muricata) Exerts Anti-Proliferative, Anti-Clonogenic and Pro-Apoptotic Effects in Human Non-Melanoma Skin Cancer UW-BCC1 and A431 Cells In Vitro: Involvement of Hedgehog SignalingJean Christopher Chamcheu, Islam Rady, Roxane-Cherille N Chamcheu, et al.
Data in Brief|March 5, 2021
Identification of new fisetin analogs as kinase inhibitors: Data on synthesis and anti-skin cancer activities evaluationTithi Roy, Samuel T Boateng, Sergette Banang-Mbeumi, et al.
Cell Reports. Medicine|July 17, 2024
PARP11 inhibition inactivates tumor-infiltrating regulatory T cells and improves the efficacy of immunotherapiesRaghavendra Basavaraja, Hongru Zhang, Ágnes Holczbauer, et al.
Leukemia|June 24, 2025
Critical roles of IKAROS and HDAC1 in regulation of heterochromatin and tumor suppression in T-cell acute lymphoblastic leukemiaYali Ding, Bing He, Daniel Bogush, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Mono-ADP-ribosylation-driven immunosuppression and cross-resistance to therapy through cancer cell intrinsic and extrinsic mechanismsYuchen Sun, Yingying Tang, Vivek T Singh, et al.
Bioorganic Chemistry|January 15, 2021
Synthesis, inverse docking-assisted identification and in vitro biological characterization of Flavonol-based analogs of fisetin as c-Kit, CDK2 and mTOR inhibitors against melanoma and non-melanoma skin cancersTithi Roy, Samuel T Boateng, Sergette Banang-Mbeumi, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
SPTBN2 promotes an immunosuppressive tumor microenvironment and cross-resistance to anti-cancer therapiesQuoc Thang Bui, Raghavendra Basavaraja, Mayura R Dhamdhere, et al.
Pageof 19